These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 369628)

  • 1. Drug latentiation in cancer chemotherapy.
    Workman P; Double JA
    Biomedicine; 1978 Oct; 28(5):255-62. PubMed ID: 369628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug metabolism by tumours: its nature, relevance and therapeutic implications.
    Michael M; Doherty MM
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):783-803. PubMed ID: 18028025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-catalyzed activation of anticancer prodrugs.
    Rooseboom M; Commandeur JN; Vermeulen NP
    Pharmacol Rev; 2004 Mar; 56(1):53-102. PubMed ID: 15001663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guide to the use of cancer chemotherapeutic agents.
    Bergevin PR; Tormey DC; Blom J
    Mod Treat; 1972 May; 9(2):185-273. PubMed ID: 4117324
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.
    Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S
    Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C--a novel target for rational anti-cancer drug design?
    Gescher A; Dale IL
    Anticancer Drug Des; 1989 Aug; 4(2):93-105. PubMed ID: 2679620
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
    Oesch S; Gertsch J
    J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
    Rowinsky EK
    J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of neoplasms].
    Osswald H
    Hippokrates; 1967 Jul; 38(13):497-506. PubMed ID: 5611578
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of solid tumors].
    Couture J; Deschênes L
    Union Med Can; 1970 Jun; 99(6):1042-4. PubMed ID: 4995299
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumoral drug metabolism: overview and its implications for cancer therapy.
    Michael M; Doherty MM
    J Clin Oncol; 2005 Jan; 23(1):205-29. PubMed ID: 15625375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approaches to new drug development in cancer chemotherapy.
    Zunino F; Capranico G; Pratesi G; Spinelli S
    Farmaco; 1992 Sep; 47(9):1115-32. PubMed ID: 1300118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of self-immolative linkers for tumour-activated prodrug therapy.
    Tranoy-Opalinski I; Fernandes A; Thomas M; Gesson JP; Papot S
    Anticancer Agents Med Chem; 2008 Aug; 8(6):618-37. PubMed ID: 18690826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy.
    Old LJ; Krakoff IH
    Clin Bull; 1975; 5(3):120-3. PubMed ID: 1227737
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cyclophosphamide for in vitro testing of cell sensitivity.
    Shrivastav S; Stone KR; Paulson DF; Bonar RA
    Cancer Res; 1980 Dec; 40(12):4443-5. PubMed ID: 7438076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of 18 months of chemotherapy with Peptichemio].
    Battelli T; Bonsignori M; Manocchi P; Perilli A
    Minerva Med; 1974 Sep; 65(62):3235-43. PubMed ID: 4609310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.